SKI Market

A+| A| A-|

Indian Indices

Sensex

77,571.74 940.09
( 1.23%)

Global Indices

Nasdaq

48,208.69 277.76
(0.58%)

Dow Jones

6,845.97 42.16
(0.62%)

Hang Seng

56,916.27 1,020.95
(1.83%)

Nikkei 225

10,579.52 -29.36
(-0.28%)

Forex

USD-INR

92.44 -0.46
(-0.50%)

EUR-INR

107.96 0.52
(0.48%)

GBP-INR

124.05 0.88
(0.72%)

JPY-INR

0.58 0.00
(0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aarey Drugs & Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524412

INE198H01019

51.1335451

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AAREYDRUGS

54.28

186.23

EPS(TTM)

Face Value()

Div & Yield %

1.21

Back

Nazara Technologies consolidated net profit declines 67.93% in the December 2025 quarter

Feb 14,2026

Net profit of Nazara Technologies declined 67.93% to Rs 9.84 crore in the quarter ended December 2025 as against Rs 30.68 crore during the previous quarter ended December 2024. Sales declined 24.07% to Rs 405.97 crore in the quarter ended December 2025 as against Rs 534.69 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	405.97	534.69	-24
OPM %	16.68	6.87	-
PBDT	74.70	55.84	34
PBT	15.00	25.32	-41
NP	9.84	30.68	-68

77,571.74 940.09 ( 1.23%)

48,208.69 277.76 (0.58%)

6,845.97 42.16 (0.62%)

56,916.27 1,020.95 (1.83%)

10,579.52 -29.36 (-0.28%)

92.44 -0.46 (-0.50%)

107.96 0.52 (0.48%)

124.05 0.88 (0.72%)

0.58 0.00 (0.32%)